Interim Report January 1 – September 30, 2025

Summary by AI BETAClose X

AddLife reported a 4 percent increase in net sales for Q3 2025, reaching SEK 2,429 million, with organic growth at 6 percent. EBITA, excluding one-off costs, rose by 17 percent to SEK 270 million, resulting in an EBITA margin of 11.1 percent. Profit after tax significantly increased by 228 percent to SEK 82 million, and earnings per share reached SEK 0.66. For January to September 2025, net sales increased by 3 percent to SEK 7,709 million, with organic growth of 4 percent. EBITA, excluding one-off costs, increased by 12 percent to SEK 920 million, yielding an EBITA margin of 11.9 percent. Profit after tax increased by 89 percent to SEK 302 million, and earnings per share amounted to SEK 2.47. The equity ratio stood at 42 percent, and return on working capital was 55 percent.

Disclaimer*

Good organic growth and strong earnings development

“AddLife’s companies performed strongly during the quarter. Organic growth was solid, margin improvement continued, earnings increased significantly, and the debt ratio was reduced, in line with our priorities and ambitions.”
Fredrik Dalborg, President and CEO

AddLife´s interim report for Q3 2025 is now available online at the company website. The interim report can be downloaded in pdf version. Visit https://reports-en.add.life/interim-report-q3-2025
 
THIRD QUARTER

  • Net sales increased by 4 percent to SEK 2,429m (2,344). The organic growth, excluding exchange rate changes, was 6 percent and the acquired growth was 1 percent.
  • EBITA excl. one-off costs increased by 17 percent to SEK 270m (230), corresponding to an EBITA margin of 11.1 percent (9.8).
  • Profit after tax increased by 228 percent to SEK 82m (25).
  • Earnings per share amounted to SEK 0.66 (0.19).
  • Cash flow from operating activities amounted to SEK 145m (137).

 JANUARY – SEPTEMBER, 2025

  • Net sales increased by 3 percent to SEK 7,709m (7,468). The organic growth, excluding exchange rate changes, was 4 percent and the acquired growth was 1 percent.
  • EBITA excl. one-off costs increased by 12 percent to SEK 920m (819), corresponding to an EBITA margin of 11.9 percent (11.0).
  • Profit after tax increased by 89 percent to SEK 302m (160).
  • Earnings per share amounted to SEK 2.47 (1.30). Earnings per share for the last 12 months amounted to SEK 3.23 (0.98).
  • Cash flow from operating activities amounted to SEK 504m (429).
  • The equity ratio was 42 percent (41).
  • Return on working capital (P/WC) amounted to 55 percent (51).
  • In April, the acquisition of Edge Medical Ltd., United Kingdom, was completed. The acquisition is expected to contribute annual net sales of approximately SEK 90m.

 
Stockholm, October 23, 2025
AddLife AB (publ)

Companies

Addlife AB (0REZ)
UK 100

Latest directors dealings